Address
SalaryAbout us
UCL is one of the U.K.’s premier research and teaching Universities (www.ucl.ac.uk), ranked within the top 15 global universities, and has one of the largest Biomedical Faculties in Europe. It is closely aligned to University College London Hospitals (UCLH) which has state-of-the-art facilities in central London (http://www.uclh.nhs.uk/),and continues to grow through a major investment in building. The UCL Cancer Institute is the hub for cancer research and translation research. In 2012 the UCH Macmillan Cancer Centre, sited directly opposite the Cancer Institute, opened. In December 2021 the Grafton Way Building, which houses the National Proton Beam Therapy Centre at UCLH and the Haematology, Transplantation and Cell Therapy inpatient unit treated its first patients. In 2019 a new Eastman Dental and Royal Ear Nose and Throat Hospital was opened. Clinical Cancer Trials has been a key component of UCL and UCLH’s research ethos. The Cancer Research UK and UCL Cancer Trials Centre (CTC) (www.ctc.ucl.ac.uk) opened in 1996 and is one of the largest academic cancer trials centres in the UK. The UCL Cancer Institute has a total grant income over £100 million, 50 scientific Group leaders, 32 clinical scientists and 50 honorary clinical consultants. The Cancer Institute is an internationally recognised centre for cancer research. UCL is an Experimental Cancer Medicine Centre. In collaboration with Queen Mary University London, the Francis Crick Institute and Kings College London, the Cancer Institute is also the hub for Cancer Research UK’s City of London Centre to develop biotherapeutics research https://www.ucl.ac.uk/cancer/research/centres-and-networks/cancer-research-uk-ucl-centre/cancer-research-uk-city-london-centre.
About the role
The postholder will be expected to develop their own research programme within Haemato-Oncology at the UCL Cancer Institute, in conjunction with University College London Hospitals (UCLH). They will develop a national profile, positioning UCL/UCLH at the forefront in this area. The UCLH/UCL partnership has been awarded Biomedical Research Centre status by the National Institute for Health Research and cancer research is one of its four major themes.
About you
The successful candidate is expected to be a Clinical Associate Professor of Haematology specialising in haemato-oncology. A track record of research in tumour immunology and a specialist interest in plasma cell disorders would be advantageous. The postholder will be expected to lead a haemato-oncology research group and to secure successful grant funding at an independent level. A track record of successful grant applications would be desirable. There are opportunities to develop an educational programme. This position will form an important part of the wider UCLH/UCL Biomedical Research Centre (BRC) portfolio, and the Cancer Research UK Centre at UCL. The appointee will be a member of the UCL Cancer Institute and will work closely with the Clinical Lead for Haematology at UCLH, Dr K. Thomson and the Clinical Director of Cancer Service, Dr Kirit Ardeshna to lead clinical academic haemato-oncology development at UCLH. In addition, they will work closely with the NHS haematologists who work in their own sub-specialty area
What we offer
As well as the exciting opportunities this role presents we also offer some great benefits some of which are below:
41 Days holiday (including 27 days annual leave 8 bank holiday and 6 closure days)
Defined benefit career average revalued earnings pension scheme (CARE)
Cycle to work scheme and season ticket loan
On-Site nursery
On-site gym
Enhanced maternity, paternity and adoption pay
Employee assistance programme: Staff Support Service
Discounted medical insurance
Our commitment to Equality, Diversity and Inclusion
As London’s Global University, we know diversity fosters creativity and innovation, and we want our community to represent the diversity of the world’s talent. We are committed to equality of opportunity, to being fair and inclusive, and to being a place where we all belong.
We therefore particularly encourage applications from candidates who are likely to be underrepresented in UCL’s workforce.
These include people from Black, Asian and ethnic minority backgrounds; disabled people; LGBTQI+ people; and for our Grade 9 and 10 roles, women.
You can read more about our commitment to Equality, Diversity and Inclusion here : https://www.ucl.ac.uk/equality-diversity-inclusion/
